NEI Research News

The Medical College of Georgia scientists have early evidence that HBI-002, a low-dose oral compound, can safely reduce oxidative stress and inflammation in the retina, both early, major contributors to diabetic retinopathy.

The National Eye Institute has released a new strategic plan. 2021 Vision for the Future charts the next five years of NEI’s mission: to eliminate vision loss and improve quality of life through vision research.

Researchers at the Max Planck Florida Institute for Neuroscience (MPFI) have uncovered a surprisingly complex yet precisely ordered map of visual space in area V2 of the cortex.

Scientists at the John A. Moran Eye Center at the University of Utah have discovered a new type of nerve cell, or neuron, in the retina. The newly identified Campana cell could play a role in visual signal processing.

An antidepressant best known as Prozac could offer the first treatment for the leading cause of blindness among people over 50, new research from the University of Virginia School of Medicine suggests.

International effort identified new and different causative gene variants for a group of diseases that can lead to severe vision loss or blindness.

A Northwestern Medicine study in mice has identified new treatment targets for glaucoma, including preventing a severe pediatric form of glaucoma, as well as uncovering a possible new class of therapy for the most common form of glaucoma in adults.

As scientists move closer to testing regenerative therapies for eye disease, techniques are needed to monitor transplanted cells as they integrate with host tissues.

Damaging DNA builds up in the eyes of patients with geographic atrophy, an untreatable, poorly understood form of age-related macular degeneration that causes blindness, new research from the University of Virginia School of Medicine reveals.

In geographic atrophy, a late form of age-related macular degeneration (AMD), reading ability is closely related to the altered retinal structure.